Compare Pfizer Inc (PFE) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Seagate Technology Holdings PLC — how do they compare? Pfizer Inc trades at $27.78 (market cap $159.59B), while Seagate Technology Holdings PLC trades at $788.25 (market cap $183.64B). The key difference: Seagate Technology Holdings PLC is the larger of the two by market cap, and Pfizer Inc pays the higher dividend (6.14%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Seagate Technology Holdings PLC for 41 Days on average.
| PFE | STX | |
|---|---|---|
Market Cap | $159.59B | $183.64B |
Volume | 30,937,010 | 4,409,190 |
Sector | Health | Technology |
52-Week High | $29.02 | $1.09K |
52-Week Low | $23.67 | $211.63 |
Typical Hold Time | 158 Days | 41 Days |
Enterprise Value | $211.09B | $185.79B |
Dividend Yield | 6.14% | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
STX trades at $774.83, down 3.82% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10, and robust profitability metrics including 26.11% net margin and 371.53% ROE. Technical indicators signal bearish momentum with price near support at $773, while analyst consensus remains positive with 53.85% buy ratings and $1,130 price target.
Despite near-term competitive pressures, STX maintains strong earnings momentum and leadership in AI storage markets. The primary risk involves Toshiba's capacity expansion potentially eroding pricing power, but projected 2026 revenue growth to $12.2B and net income of $3.2B support long-term upside. Current valuation at 58.1 P/E reflects growth expectations amid technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
